GO-Tibia: a masked, randomized control trial evaluating gentamicin versus saline in open tibia fractures.
Billy T Haonga, Jamieson M O'Marr, Patrick Ngunyale...
https://pubmed.ncbi.nlm.nih.gov/37322521/Actively Recruiting
Led by University of California, San Francisco · Updated on 2026-09-10
890
Participants Needed
1
Research Sites
52 weeks
Total Duration
Open tibia fractures, which expose the shinbone through the skin, often lead to infections and complications that can cause long-term disability or amputation. Researchers are evaluating the effect of applying the antibiotic gentamicin directly to these open wounds to see if it reduces infection risk. This is the first randomized clinical trial to test this local antibiotic approach in such fractures, with potential to improve care worldwide, especially in low-income countries. Participants will receive either gentamicin liquid or a saline solution injected directly into the fracture wound during surgery. Both treatments involve injecting 5 mL of solution at the fracture site using a small needle. The gentamicin dose is 80 mg diluted in saline. The study compares infection rates between those receiving gentamicin and those receiving saline, with all other care being standard. During the 12-month participation, patients will be monitored for fracture-related infections, bone healing, need for additional surgery, and quality of life using questionnaires and imaging assessments. Researchers will track healing progress and any complications over this period. The study is randomized and blinded to keep treatment assignment unbiased, and participation includes regular follow-up visits to measure health outcomes and safety.
CONDITIONS
Gentamicin Open Tibia Study
D
David W Shearer, MD, MPH
T
Tigist Belaye, MPA
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of California, San Francisco
Lead Sponsor
Muhimbili Orthopaedic Institute
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single treatment during surgery
Participants receive either gentamicin or saline injected locally into the open tibia fracture wound during surgery.
1 visit during surgery
Duration - 12 months
Participants are monitored for 12 months to assess infection occurrence, bone healing, need for additional surgery, and quality of life.
Regular follow-up visits during 12 months
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Billy T Haonga, Jamieson M O'Marr, Patrick Ngunyale...
https://pubmed.ncbi.nlm.nih.gov/37322521/University of California, San Francisco
Lead Sponsor
Muhimbili Orthopaedic Institute
Collaborating Sponsor